RxDoctor Payments Data

David Smith, DPM

Podiatrist · Hopkinsville, KYNPI 1538332010

Payments from drug & device makers

What this record shows

This record is dominated by other: $54,480 of the $66,455 with a category attached, or 82.0%. Convatec Inc. accounts for 82.1% of it on its own, with 41 other manufacturers making up the rest. Reporting peaked in 2024 at $56,713 and has fallen 94.9% since, to $2,900 in 2025. Among podiatrist clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$66,455in general payments, 2019–2025

Across 278 payments — averaging $239.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$55K
  • Averitas Pharma Inc.$4K
  • Smith+Nephew$3K
  • Stryker$583
  • GRT US Holding, Inc.$525
  • Organogenesis Inc.$517
  • plus $3K from 36 others

What the payments were for

  • Consulting fees$2,5594%
  • Speaking & faculty fees$1,0622%
  • Travel & lodging$1,1652%
  • Food & beverage$7,06911%
  • Education$1210%
  • Other$54,48082%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,455 in reported general payments places this provider in the 95th percentile of 54 podiatrist providers in Kentucky.

See all podiatrist providers in Kentucky

Medicare billing

Part B allowed, 2024
$364,602
Medicare patients
368
Services billed
22,641

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Calcipotriene12$5,671
Duloxetine Hcl37$808
Ketoconazole23$663
Gabapentin24$369

Paid to pharmacies, not to this prescriber.

Other podiatrist in Hopkinsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →